一个反堕胎组织要求 FDA 在对米非司酮的审查中无视其所谓的“深层政府”研究，这加剧了关于堕胎机会和科学诚信的政治冲突。 An anti-abortion group demands the FDA disregard research it calls "Deep State" in its review of mifepristone, fueling political clashes over abortion access and scientific integrity.

一个反堕胎团体敦促联邦监管机构在FDA审查药物堕胎药丸期间, 排除其贴上“深度国家”标签的资料来源中的数据, An anti-abortion group is urging federal regulators to exclude data from sources it labels "Deep State" during the FDA's review of medication abortion pills, citing concerns over perceived liberal bias in scientific research. 这一呼吁是随着各国继续限制远程保健和邮购获得堕胎药物而发出的,反映了在生殖权利问题上不断的政治和法律斗争。 The call comes as states continue to restrict telehealth and mail-order access to abortion medications, reflecting ongoing political and legal battles over reproductive rights. 美国食品和药物管理局仍在评估米费普里斯的安全性和有效性, 但这一争议突出了关于证据如何影响健康政策的深层分歧. The FDA is still evaluating the safety and efficacy of mifepristone, but the controversy highlights deep divisions over how evidence should inform health policy.